Cabaletta Bio Inc. (NASDAQ:CABA) went up by 7.41% from its latest closing price compared to the recent 1-year high of $11.91. The company’s stock price has collected 9.88% of gains in the last five trading sessions.
Is It Worth Investing in Cabaletta Bio Inc. (NASDAQ :CABA) Right Now?
Opinions of the stock are interesting as 6 analysts out of 7 who provided ratings for Cabaletta Bio Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $10.67, which is -$0.34 below the current price. CABA currently public float of 27.61M and currently shorts hold a 12.78% ratio of that float. Today, the average trading volume of CABA was 1.06M shares.
CABA’s Market Performance
CABA stocks went up by 9.88% for the week, with a monthly jump of 54.42% and a quarterly performance of 461.73%, while its annual performance rate touched 268.23%. The volatility ratio for the week stands at 14.59% while the volatility levels for the past 30 days are set at 15.94% for Cabaletta Bio Inc. The simple moving average for the period of the last 20 days is 16.07% for CABA stocks with a simple moving average of 324.03% for the last 200 days.
Analysts’ Opinion of CABA
Many brokerage firms have already submitted their reports for CABA stocks, with Morgan Stanley repeating the rating for CABA by listing it as a “Equal-Weight.” The predicted price for CABA in the upcoming period, according to Morgan Stanley is $3 based on the research report published on August 30th of the previous year 2022.
Wells Fargo, on the other hand, stated in their research note that they expect to see CABA reach a price target of $17. The rating they have provided for CABA stocks is “Overweight” according to the report published on December 08th, 2021.
Morgan Stanley gave a rating of “Overweight” to CABA, setting the target price at $20 in the report published on October 19th of the previous year.
CABA Trading at 70.33% from the 50-Day Moving Average
After a stumble in the market that brought CABA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -7.56% of loss for the given period.
Volatility was left at 15.94%, however, over the last 30 days, the volatility rate increased by 14.59%, as shares surge +29.23% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +409.72% upper at present.
During the last 5 trading sessions, CABA rose by +9.88%, which changed the moving average for the period of 200-days by +429.33% in comparison to the 20-day moving average, which settled at $9.61. In addition, Cabaletta Bio Inc. saw 19.03% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at CABA starting from Nichtberger Steven, who purchase 8,127 shares at the price of $1.25 back on Oct 19. After this action, Nichtberger Steven now owns 986,483 shares of Cabaletta Bio Inc., valued at $10,152 using the latest closing price.
Simon Mark, the Director of Cabaletta Bio Inc., purchase 7,000 shares at $0.98 during a trade that took place back on Oct 18, which means that Simon Mark is holding 7,000 shares at $6,835 based on the most recent closing price.
Stock Fundamentals for CABA
Equity return is now at value -50.40, with -47.20 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 14.86.